Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Why and how transwomen are switching to funded oestrogen gel
Why and how transwomen are switching to funded oestrogen gel

With oestrogen gel now funded without restrictions, sexual health specialist Massimo Giola explains who would benefit from using it for feminisation and how switching from tablets or patches might occur
1. Scheres LJJ, Selier NLD, Nota NM, et al. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen. J Thromb Haemost 2021;19(4):1029–37.
2. Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 2022;23(Suppl 1):S1–259.
3. Veale JF. Transgender-related stigma and gender minority stress-related health disparities in Aotearoa New Zealand: hypercholesterolemia, hypertension, myocardial infarction, stroke, diabetes, and general health. Lancet Reg Health West Pac 2023;39:100816.
4. Australasian Menopause Society. AMS Guide to MHT/HRT Doses New Zealand only. 21 October 2024.